Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 15th, there was short interest totalling 13,510,000 shares, an increase of 35.1% from the May 31st total of 10,000,000 shares. Based on an average daily volume of 1,340,000 shares, […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 10,000,000 shares, an increase of 7.2% from the May 15th total of 9,330,000 shares. Approximately 21.5% of the company’s shares are short sold. […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Rating) major shareholder Ai Day1 Llc acquired 769,230 shares of the company’s stock in a transaction dated Friday, June 9th. The stock was purchased at an average cost of $13.00 per share, with a total value of $9,999,990.00. Following the completion of the purchase, the insider now directly […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Rating)’s share price gapped up prior to trading on Tuesday after an insider bought additional shares in the company. The stock had previously closed at $12.54, but opened at $13.00. Day One Biopharmaceuticals shares last traded at $13.56, with a volume of 197,640 shares changing hands. Specifically, CEO […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Rating) insider Samuel C. Blackman sold 1,229 shares of the company’s stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $16.00, for a total value of $19,664.00. Following the completion of the transaction, the insider now owns 1,234,363 shares in […]